# Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT – FDA Inspections

Source: https://www.keypedia.com/companies/boehringer-ingelheim-pharmaceuticals-inc/437c28a1-054f-4c22-9dba-fd40af58a7be

> Inspection records and compliance data for Boehringer Ingelheim Pharmaceuticals, Inc. in Ridgefield, Connecticut. 20 FDA inspections on record, 5 Form 483s, last inspected August 25, 2026.

---

## Details

- Name: Boehringer Ingelheim Pharmaceuticals, Inc.
- FEI Number: 1219205
- Address Line 1: 900 Ridgebury Rd
- City: Ridgefield
- State: Connecticut
- Zip Code: 06877
- Country Name: United States
- Address: 900 Ridgebury Rd, Ridgefield, Connecticut 06877, United States
- Country: United States

## Related Documents

- FDA Inspection 1334848 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2026-08-25 — source: FDA, date: August 25, 2026
- [483 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2025-09-11](https://www.keypedia.com/records/483/boehringer-ingelheim-pharmaceuticals-inc/6394b726-4080-4f87-8203-78db8a187c7a) — source: FDA, date: September 11, 2025
- [FDA Inspection 1281125 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2025-09-11](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/9c62d459-d5fc-4614-8d41-987968509962) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2025
- FDA Inspection 1281125 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2025-09-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2025
- FDA Inspection 1235545 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2024-05-02 — source: FDA, date: May 2, 2024
- FDA Inspection 1219707 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2023-09-22 — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2023
- [483 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2019-12-12](https://www.keypedia.com/records/483/boehringer-ingelheim-pharmaceuticals-inc/da8d3965-3386-4e4e-9c75-c73516a4a7a1) — source: FDA, date: December 12, 2019
- [FDA Inspection 1112627 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2019-12-12](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/3cec078a-63a0-4054-aba3-a7b39a8fad4e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2019
- [FDA Inspection 1073537 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2018-12-06](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e71d8ac5-5980-4791-92de-944874b88e24) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2018
- [FDA Inspection 1066876 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2018-07-03](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e785d17b-1b62-499e-b933-e90b9174d6e7) — source: FDA, date: July 3, 2018
- [FDA Inspection 1019749 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2017-07-28](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/e3b667cd-82de-4b3a-a62c-e7c7a8a04994) — source: FDA, date: July 28, 2017
- [FDA Inspection 1004536 - Boehringer Ingelheim Pharmaceuticals, Inc. - 2017-02-28](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-pharmaceuticals-inc/348dac8e-c7ba-4f7a-aacc-cec40017cc2a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2017
- [EIR - Boehringer Ingelheim Pharmaceuticals, Inc. - 2010-09-01](https://www.keypedia.com/records/eir/boehringer-ingelheim-pharmaceuticals-inc/c2f00c08-0e01-4f3f-bbfa-5466b71914d6) — source: FDA, date: September 1, 2010

## Related Companies

- [Pharmacyclics LLC](https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8)
- [Gilead Sciences Inc](https://www.keypedia.com/companies/gilead-sciences-inc/25d591ee-1217-4ca3-9134-ed69477f677f)
- [SC Johnson Professional USA, Inc.](https://www.keypedia.com/companies/sc-johnson-professional-usa-inc/e9b50d00-3095-4f01-9e05-4f21adc9812a)
- [Pfizer Inc.](https://www.keypedia.com/companies/pfizer-inc/95f0f34c-638b-4a6b-8c65-35fb37711e6b)
- [Rajinder S. Shiwach, M.D.](https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec)
- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)
- [BioTel Research, LLC](https://www.keypedia.com/companies/biotel-research-llc/2a9f13e0-a9ee-4e1b-a154-2190996d80db)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Bausch Health Americas, Inc.](https://www.keypedia.com/companies/bausch-health-americas-inc/46368cf4-fd1b-4ed0-a010-ae5ccd022cb6)
- [Bristol-Myers Squibb Company](https://www.keypedia.com/companies/bristol-myers-squibb-company/f88df458-d615-433c-956b-d484506e4986)

## Related Officers

- [investigator](https://www.keypedia.com/people/michelle-m-noe/8e925eca-5177-4ada-a6a9-47191cc42367)
- [investigator](https://www.keypedia.com/people/m-patricia-murphy/e955e45d-f8e3-46d3-a712-50dd075ca43c)
- [Miah Jung](https://www.keypedia.com/people/miah-jung/8d4c33e9-7fd9-4a9d-856b-05a24e1566d4)
- [Cynthia Kleppinger](https://www.keypedia.com/people/cynthia-kleppinger/8badb3bc-141f-4094-a02b-b572fdb68fbf)
- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)
